Calverley PM, Georgopopoulos D: Chronic obstructive pulmonary disease: symptoms and signs. Eur Respir Mon. 2006, 38: 7-23.
Google Scholar
Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004, 23: 932-946. 10.1183/09031936.04.00014304.
Article
PubMed
CAS
Google Scholar
Chong-Chen LU: Bronchodilator therapy for chronic obstructive pulmonary disease. Respirology. 1997, 2: 317-322. 10.1111/j.1440-1843.1997.tb00096.x.
Article
Google Scholar
Draft guidance for industry on chronic obstructive pulmonary disease: developing drugs for treatment; availability. Fed Regist. 2007, 72: 63618-
Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of COPD. [], [http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf]
Siafakas NM, Celli B: Overall management of stable chronic obstructive pulmonary disease. Eur Respir Mon. 2006, 38: 258-265.
Google Scholar
Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L: Definition, epidemiology and natural history of COPD. Eur Respir J. 2007, 30: 993-1013. 10.1183/09031936.00082507.
Article
PubMed
CAS
Google Scholar
Cooper CB: The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006, 119 (Suppl 1): 21-31. 10.1016/j.amjmed.2006.08.004.
Article
PubMed
Google Scholar
Ries AL: Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea. Am J Med. 2006, 119 (Suppl 1): 12-20. 10.1016/j.amjmed.2006.08.003.
Article
PubMed
Google Scholar
Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T: Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011, 20: 257-268. 10.4104/pcrj.2011.00029.
Article
PubMed
Google Scholar
Leidy NK, Wilcox TK, Jones PW, Murray L, Winnette R, Howard K, Petrillo J, Powers J, Sethi S: Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health. 2010, 13: 965-975. 10.1111/j.1524-4733.2010.00772.x.
Article
PubMed
Google Scholar
Jones PW, Chen WH, Wilcox TK, Sethi S, Leidy NK: Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest. 2011, 139: 1388-1394. 10.1378/chest.10-1240.
Article
PubMed
Google Scholar
Leidy NK, Wilcox TK, Jones PW, Roberts L, Powers JH, Sethi S: Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med. 2011, 183: 323-329. 10.1164/rccm.201005-0762OC.
Article
PubMed
Google Scholar
Leidy NK, Murray LT, Jones P, Sethi S: Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014, 11: 316-325. 10.1513/AnnalsATS.201309-305OC.
Article
PubMed
Google Scholar
Leidy NK, Murray LT: Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS. COPD. 2013, 10: 393-398. 10.3109/15412555.2013.795423.
Article
PubMed
Google Scholar
Draft guidance for industry on qualification of exacerbations of chronic pulmonary disease tool for measurement of symptoms of acute bacterial exacerbations of chronic bronchitis in patients with chronic obstructive pulmonary disease. Fed Regist. 2014, 79: 1873-1874.
Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist. 2009, 74: 65132-65133.
Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L: Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1-eliciting concepts for a new PRO instrument. Value Health. 2011, 14: 967-977. 10.1016/j.jval.2011.06.014.
Article
PubMed
Google Scholar
Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L: Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2-assessing respondent understanding. Value Health. 2011, 14: 978-988. 10.1016/j.jval.2011.06.013.
Article
PubMed
Google Scholar
Leidy NK, Sexton CC, Jones PW, Notte SM, Monz BU, Nelsen L, Goldman M, Murray LT, Sethi S: Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax. 2014, 69: 424-430. 10.1136/thoraxjnl-2013-204428.
Article
PubMed Central
Google Scholar
Vogelmeier C, Aquino TO, O'Brien CD, Perrett J, Gunawardena KA: A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium. COPD. 2012, 9: 111-120. 10.3109/15412555.2011.641803.
Article
PubMed
Google Scholar
Kuna P, Jenkins M, O'Brien CD, Fahy WA: AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD. Respir Med. 2012, 106: 531-539. 10.1016/j.rmed.2011.10.020.
Article
PubMed
Google Scholar
Leidy NK, Schmier JK, Jones MK, Lloyd J, Rocchiccioli K: Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough and Sputum Scale. Respir Med. 2003, 97 (Suppl A): S59-S70. 10.1016/S0954-6111(03)80016-1.
Article
PubMed
Google Scholar
Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M: The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest. 2003, 124: 2182-2191. 10.1378/chest.124.6.2182.
Article
PubMed
Google Scholar
Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992, 145: 1321-1327. 10.1164/ajrccm/145.6.1321.
Article
PubMed
CAS
Google Scholar
Fletcher CM, Elmes PC, Fairbairn AS, Wood CH: The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959, 2: 257-266. 10.1136/bmj.2.5147.257.
Article
PubMed
CAS
PubMed Central
Google Scholar
Leidy NK, Knebel A: Clinical validation of the Functional Performance Inventory in patients with COPD. Respir Care. 1999, 44: 932-939.
Google Scholar
Leidy NK, Hamilton A, Becker K: Assessing patient report of function: content validity of the Functional Performance Inventory-Short Form (FPI-SF) in patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2012, 7: 543-554. 10.2147/COPD.S32032.
Article
PubMed
PubMed Central
Google Scholar
Jones PW: St. George's Respiratory Questionnaire: MCID. COPD. 2005, 2: 75-79. 10.1081/COPD-200050513.
Article
PubMed
Google Scholar
Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, Wise RA, Sciurba F: The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011, 37: 784-790. 10.1183/09031936.00063810.
Article
PubMed
CAS
Google Scholar
Singh SJ, Jones PW, Evans R, Morgan MD: Minimum clinically important improvement for the incremental shuttle walking test. Thorax. 2008, 63: 775-777. 10.1136/thx.2007.081208.
Article
PubMed
CAS
Google Scholar
Hays RD, Anderson RT, Revicki DA: Assessing reliability and validity of measurement in clinical trials. Quality of Life Assessment in Clinical Trials: Methods and Practice. Edited by: Staquet MJ, Hays RD. 1998, Oxford University Press, New York, 169-182.
Google Scholar
Nunnally JC, Bernstein IH: Psychometric Theory. 1994, McGraw-Hill, New York
Google Scholar
Chinn S: Statistics in respiratory medicine. 2. Repeatability and method comparison. Thorax. 1991, 46: 454-456. 10.1136/thx.46.6.454.
Article
PubMed
CAS
PubMed Central
Google Scholar
Assessing Quality of Life in Clinical Trials: Methods and Practice. 2005, Oxford University Press, New York
Rutten-van Molken M, Roos B, Van Noord JA: An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax. 1999, 54: 995-1003. 10.1136/thx.54.11.995.
Article
PubMed
CAS
Google Scholar
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.
Article
PubMed
CAS
Google Scholar
Gupta N, Pinto LM, Morogan A, Bourbeau J: The COPD assessment test: a systematic review.Eur Respir J 2014. in press.,
Johnston N, O'Byrne P, Kolb M: The promise of electronic data capture in respiratory medicine. Eur Respir J. 2011, 37: 228-230. 10.1183/09031936.00141310.
Article
PubMed
CAS
Google Scholar
Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA: Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014, 189 (3): 250-255. 10.1164/rccm.201310-1863PP.
Article
PubMed
Google Scholar
Beier J, Kirsten AM, Mroz R, Segarra R, Chuecos F, Caracta C, Gil EG: Efficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb study. COPD. 2013, 10: 511-522. 10.3109/15412555.2013.814626.
Article
PubMed
PubMed Central
Google Scholar